Psychiatrists Absent from Cost-of-Care Discussions
the Psychiatry Advisor take:
Mental health services are tied with cancer as the third most expensive medical treatment in the United States, behind only heart conditions and trauma, according to researchers in JAMA Psychiatry.
Spending on psychiatric medications alone was $34 billion in 2005, surpassing expenditures on cancer drugs by $8 billion. Yet many mental health providers experience chronic underfunding for other mental health services.
Despite these issues, and growing concerns about the escalating costs of U.S. health care overall, psychiatrists remain largely absent from discussions about how to control spending.
Andres Barkil-Oteo, MD, MSc, of Yale School of Medicine, David A. Stern, MD, of New York Medical College, and Melissa R. Arbuckle, MD, PhD, of Columbia University Medical Center, discuss how front-line psychiatrists can become more involved in these efforts.
They address issues including lack of transparency about the actual cost of care, discomfort discussing treatment costs with patients and lack of incorporating cost considerations into medical training for upcoming generations of psychiatrists, as well as potential solutions to these problems.
Addressing the Cost of Health Care
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Transference in the Age of #MeToo: What Counts as Harassment From a Patient?
- Models Derived From Electronic Health Records Effective in Predicting Suicide Risk
- Autonomic Function May Have Directional Effect on Depression
- Predictors of Long-term Medication Adherence in Children With ADHD
- Probiotics Effective in Reducing Rehospitalization for Patients With Mania
- Court-Mandated Substance Abuse Treatment: Exploring the Ethics and Efficacy
- ADHD Treatments
- Pharmacogenetics in Psychiatry: Promising Developments and Potential Pitfalls
- Esketamine Nasal Spray: A New Treatment Possibility for Treatment-Resistant Depression
- Substance Abuse and Primary Psychosis: A Closer Look